QGEN

QGEN

USD

Qiagen N.V. Common Shares

$44.160-1.160 (-2.560%)

Precio en Tiempo Real

Healthcare
Diagnostics & Research
Países Bajos

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$45.320

Máximo

$47.355

Mínimo

$43.260

Volumen

0.66M

Fundamentos de la Empresa

Capitalización de Mercado

9.6B

Industria

Diagnostics & Research

País

Netherlands

Estadísticas de Negociación

Volumen Promedio

1.21M

Bolsa

NYQ

Moneda

USD

Rango de 52 Semanas

Mínimo $37.63Actual $44.160Máximo $51.88

Noticias Relacionadas

BusinessWire

QIAGEN Unveils QIAsymphony Connect and Showcases New Precision Oncology Innovations at AMP 2025

QIAsymphony Connect, the next generation of automated nucleic acid purification platform, to be shown at AMP 2025 as early access phase begins ahead of full release in mid-2026 QIAGEN showcases Sample to Insight

Ver más
QIAGEN Unveils QIAsymphony Connect and Showcases New Precision Oncology Innovations at AMP 2025
BusinessWire

QIAGEN to acquire Parse Biosciences, expanding its Sample technologies portfolio into highly scalable single-cell solutions

Parse Biosciences is a fast-growing innovator in single-cell sample preparation, with technologies used in more than 3,000 labs across over 40 countries Acquisition strengthens QIAGEN's presence in the rapidly

Ver más
QIAGEN to acquire Parse Biosciences, expanding its Sample technologies portfolio into highly scalable single-cell solutions
BusinessWire

QIAGEN Exceeds Q3 2025 Outlook, Raises FY 2025 Adj. EPS Target, Announces Parse Acquisition and $500 Million Share Repurchase

Q3 2025 results: Net sales of $533 million (+6% at actual rates); diluted EPS $0.60 Core sales +6% CER (constant exchange rates) driven by QIAstat-Dx (+11% CER), QuantiFERON (+11% CER) and Sample technologies (+3%

Ver más
QIAGEN Exceeds Q3 2025 Outlook, Raises FY 2025 Adj. EPS Target, Announces Parse Acquisition and $500 Million Share Repurchase
BusinessWire

QIAGEN Launches New Automated Sexual Assault Sample Processing Kit at ISHI 2025

New EZ2 DNA Investigator Sep&Prep Kit automates sexual assault sample processing, improving sperm DNA recovery and separation from victim DNA Workflow on EZ2 Connect Fx delivers high-quality DNA in under 2.5

Ver más
QIAGEN Launches New Automated Sexual Assault Sample Processing Kit at ISHI 2025
BusinessWire

QIAGEN Marks 4,000th QIAcube Connect Placement, Reaffirming Leadership in Automated Sample Processing

QIAcube Connect drives lab efficiency by automating critical steps in molecular biology workflows for both research and clinical customers Milestone builds on nearly 13,000 cumulative placements of QIAcube family

Ver más
QIAGEN Marks 4,000th QIAcube Connect Placement, Reaffirming Leadership in Automated Sample Processing

Mantente Actualizado

Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.